• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖儿童生长激素释放激素的分泌

Secretion of growth hormone releasing hormone in obese children.

作者信息

Loche S, Balzano S, Bozzola M, Moretta A, Pintus S, Faedda A, Muntoni A, Carta D, Pintor C

机构信息

Istituto di Clinica Pediatrica, Università di Cagliari, Italy.

出版信息

J Endocrinol Invest. 1992 Jun;15(6):453-7. doi: 10.1007/BF03348770.

DOI:10.1007/BF03348770
PMID:1401748
Abstract

We have evaluated baseline and l-dopa-stimulated peripheral growth hormone releasing hormone (pGHRH) secretion in 6 obese pre-pubertal children and in 7 age-matched controls. Baseline pGHRH levels were no different between obese (36.6 +/- 9.8 pg/ml, mean +/- SE) and control children (40.6 +/- 10.1 pg/ml). Administration of l-dopa (500 mg po) caused a significant increase of pGHRH levels in both the obese (65.3 +/- 19.8 pg/ml, p less than 0.05) and the control children (84.1 +/- 10.0 pg/ml, p less than 0.003). Mean peak pGHRH levels after l-dopa were not significantly different between the two groups, whereas mean peak GH levels were significantly lower (p less than 0.05) in the obese (7.9 +/- 1.9 ng/ml) than in the control children (20.5 +/- 4.9 ng/ml). We conclude that despite reduced GH secretion, obese children have normal baseline and l-dopa stimulated pGHRH levels.

摘要

我们评估了6名肥胖青春期前儿童和7名年龄匹配的对照儿童的基础状态及左旋多巴刺激后的外周生长激素释放激素(pGHRH)分泌情况。肥胖儿童(36.6±9.8 pg/ml,均值±标准误)和对照儿童(40.6±10.1 pg/ml)的基础pGHRH水平无差异。给予左旋多巴(口服500 mg)后,肥胖儿童(65.3±19.8 pg/ml,p<0.05)和对照儿童(84.1±10.0 pg/ml,p<0.003)的pGHRH水平均显著升高。两组左旋多巴刺激后的pGHRH平均峰值水平无显著差异,而肥胖儿童(7.9±1.9 ng/ml)的生长激素(GH)平均峰值水平显著低于对照儿童(20.5±4.9 ng/ml)(p<0.05)。我们得出结论,尽管肥胖儿童的GH分泌减少,但其基础状态及左旋多巴刺激后的pGHRH水平正常。

相似文献

1
Secretion of growth hormone releasing hormone in obese children.肥胖儿童生长激素释放激素的分泌
J Endocrinol Invest. 1992 Jun;15(6):453-7. doi: 10.1007/BF03348770.
2
Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.青春期发育延迟儿童在青春期开始前后刺激生长激素(GH)分泌:与外周血浆生长激素释放激素和生长抑素水平的关系。
J Clin Endocrinol Metab. 1992 Feb;74(2):272-8. doi: 10.1210/jcem.74.2.1346143.
3
Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
J Clin Endocrinol Metab. 1985 Jun;60(6):1132-4. doi: 10.1210/jcem-60-6-1132.
4
Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
Metabolism. 1990 Sep;39(9):892-6. doi: 10.1016/0026-0495(90)90296-o.
5
Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.吡啶斯的明激活胆碱能受体可恢复肥胖受试者生长激素(GH)对生长激素释放激素给药的反应性:下丘脑生长抑素能参与肥胖患者GH释放减弱的证据。
J Clin Endocrinol Metab. 1989 Feb;68(2):290-3. doi: 10.1210/jcem-68-2-290.
6
Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.在正常和肥胖受试者中,阿西莫司通过降低血清游离脂肪酸,增强生长激素(GH)对生长激素释放激素的反应,无论是否使用吡啶斯的明。
J Clin Endocrinol Metab. 1995 Aug;80(8):2495-8. doi: 10.1210/jcem.80.8.7629249.
7
Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.生长激素神经分泌功能障碍患儿多巴胺能和α-肾上腺素能功能的保留
J Clin Endocrinol Metab. 1986 Oct;63(4):968-73. doi: 10.1210/jcem-63-4-968.
8
Age-related decrease in plasma growth hormone: response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
Metabolism. 1991 Dec;40(12):1257-62. doi: 10.1016/0026-0495(91)90025-r.
9
L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans.左旋多巴可刺激人体下丘脑生长激素释放激素的释放。
J Clin Endocrinol Metab. 1986 Mar;62(3):466-73. doi: 10.1210/jcem-62-3-466.
10
Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.肥胖患者单独使用胃饥饿素或联合生长激素释放激素(GHRH)后出现显著的生长激素(GH)分泌。
Clin Endocrinol (Oxf). 2004 Aug;61(2):250-5. doi: 10.1111/j.1365-2265.2004.02092.x.

引用本文的文献

1
Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.普拉德-威利综合征中生长激素(GH)对生长激素释放六肽(GHRP-6)反应性的损害。
J Endocrinol Invest. 2001 May;24(5):340-8. doi: 10.1007/BF03343871.
2
GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology.普拉德-威利综合征中的生长激素/胰岛素样生长因子-I轴:胰岛素样生长因子-I水平及生长激素细胞对各种刺激的反应性评估。意大利儿科学内分泌与糖尿病学会遗传肥胖研究组
J Endocrinol Invest. 2000 Feb;23(2):84-9. doi: 10.1007/BF03343684.
3

本文引用的文献

1
Endocrine function in human obesity.人类肥胖中的内分泌功能。
Metabolism. 1981 Jan;30(1):89-104. doi: 10.1016/0026-0495(81)90224-9.
2
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction.肥胖患者生长激素对生长激素释放因子的反应受损。垂体缺陷可通过减轻体重得到逆转。
N Engl J Med. 1984 Nov 29;311(22):1403-7. doi: 10.1056/NEJM198411293112203.
3
Distribution of immunoreactive growth hormone-releasing hormone in the human brain and intestine and its production by tumors.
Growth hormone binding protein activity in obese children.
J Endocrinol Invest. 1998 Jul-Aug;21(7):441-4. doi: 10.1007/BF03347323.
4
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.内源性生长激素释放激素是生长激素对药理刺激产生反应所必需的。
J Clin Invest. 1996 Feb 15;97(4):934-40. doi: 10.1172/JCI118516.
免疫反应性生长激素释放激素在人脑和肠道中的分布及其在肿瘤中的产生。
J Clin Endocrinol Metab. 1984 Oct;59(4):747-51. doi: 10.1210/jcem-59-4-747.
4
Distribution of growth hormone-releasing hormone-like immunoreactivity in human tissue extracts.生长激素释放激素样免疫反应性在人体组织提取物中的分布
J Clin Endocrinol Metab. 1984 Aug;59(2):263-8. doi: 10.1210/jcem-59-2-263.
5
Plasma GH responses to GHRH and insulin-induced hypoglycemia in man.
J Clin Endocrinol Metab. 1985 Jun;60(6):1265-7. doi: 10.1210/jcem-60-6-1265.
6
Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children.
J Clin Endocrinol Metab. 1985 Jun;60(6):1132-4. doi: 10.1210/jcem-60-6-1132.
7
Stimulation by food of peripheral plasma immunoreactive growth hormone releasing factor.食物对外周血浆免疫反应性生长激素释放因子的刺激作用。
Clin Endocrinol (Oxf). 1985 Mar;22(3):337-40. doi: 10.1111/j.1365-2265.1985.tb03245.x.
8
Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin.生长调节素和胰岛素对培养的人垂体腺瘤生长激素释放的调节
J Clin Endocrinol Metab. 1985 Jun;60(6):1204-9. doi: 10.1210/jcem-60-6-1204.
9
Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.正常男性中血浆生长激素释放激素的变化以及生长激素对可乐定、左旋多巴和胰岛素的反应
J Clin Endocrinol Metab. 1988 Oct;67(4):845-9. doi: 10.1210/jcem-67-4-845.
10
Insulinhypoglycemia but not arginine infusion stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children.胰岛素低血糖症而非精氨酸输注会刺激儿童循环血浆中生长激素释放激素(GHRH)的浓度。
Horm Metab Res. 1987 Sep;19(9):434-6. doi: 10.1055/s-2007-1011845.